Revenue
2022
2023
2024
2025
Century Therapeutics, Inc. (IPSC)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $109.2M | $6.6M | $2.2M | $5.2M | — | — |
| Research & development | $95.7M | $107.2M | $92.7M | $97.2M | $75.6M | $39.7M |
| Operating expenses | $126.4M | $144.7M | $148.8M | $139.0M | $94.9M | $53.9M |
| Operating income | −$17.3M | −$138.1M | −$146.5M | −$133.8M | −$94.9M | −$53.9M |
| Net income | −$9.6M | −$126.6M | −$136.7M | −$130.9M | −$95.8M | −$53.6M |
| Basic EPSper diluted share | -$0.14 | -$1.61 | -$2.30 | -$2.27 | -$2.96 | -$7.16 |
| Diluted EPSper diluted share | -$0.14 | -$1.61 | -$2.30 | -$2.96 | -$2.96 | -$7.16 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 | Russotti GregorySee Remarks | SellCommon Stock | 2.6K | $2.23 | $5.8K | 512.3K |
| Jun 12, 2026Form 4 | Carr DouglasSVP Finance & Operations | SellCommon Stock | 1.7K | $2.23 | $3.7K | 505.1K |
| Jun 8, 2026Form 4 | Russotti GregorySee Remarks | SellCommon Stock | 524 | $2.11 | $1.1K | 514.9K |
| Jun 8, 2026Form 4 | Carr DouglasSVP Finance & Operations | SellCommon Stock | 249 | $2.11 | $525.39 | 506.7K |
| May 4, 2026Form 4 | Carr DouglasSVP Finance & Operations | SellCommon Stock | 264 | $2.34 | $617.76 | 507.0K |